VNDA’s 2023 Market Dance: Up 28.68% – Time to Invest?

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded an increase of 28.68%. However, over the last six months, the performance has been weaker by 30.22%. The price of VNDA increased 27.17% over the last 30 days. And in the last five days, it has surged by 40.68%.

Vanda Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $7.00 on 05/05/23, and the lowest price during the same period was recorded at $3.30 on 11/10/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


52-week price history of VNDA Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Vanda Pharmaceuticals Inc’s current trading price is -22.42% away from its 52-week high, while its distance from the 52-week low is 64.80%. The stock’s price range over this timeframe has been between $3.30 and $7.00. The shares of the Healthcare sector company recorded a trading volume of approximately 41.65 million for the day, which was comparatively higher than the average daily volume of 0.99 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Vanda Pharmaceuticals Inc (VNDA) has experienced a quarterly rise of 20.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 312.46M and boasts a workforce of 203 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.94, with a change in price of +1.05. Similarly, Vanda Pharmaceuticals Inc recorded 1,381,636 in trading volume during the last 100 days, posting a change of +23.59%.

VNDA’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for VNDA stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.

VNDA Stock Stochastic Average

The raw stochastic average for Vanda Pharmaceuticals Inc over the last 50 days is presently at 78.40%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 76.08%. Further, the company’s Stochastic %K and %D values for the last 20 days were 49.85% and 42.79%, respectively.

On Key

Related Posts